| Home > Publications database > Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas. > print |
| 001 | 302111 | ||
| 005 | 20251002115236.0 | ||
| 024 | 7 | _ | |a 10.1038/s41467-025-60519-5 |2 doi |
| 024 | 7 | _ | |a pmid:40523919 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC12170903 |2 pmc |
| 024 | 7 | _ | |a altmetric:178118214 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-01243 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 500 |
| 100 | 1 | _ | |a Imle, Roland |0 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas. |
| 260 | _ | _ | |a [London] |c 2025 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1750253028_2011 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a DKFZ-ZMBH Alliance / #EA:B380#LA:B380# |
| 520 | _ | _ | |a A major challenge hampering therapeutic advancements for high-risk sarcoma patients is the broad spectrum of molecularly distinct sarcoma types and the corresponding lack of suitable model systems. Here we describe the development of a genetically-controlled, yet versatile mouse modeling platform allowing delivery of different genetic lesions by muscle electroporation (EPO) in wildtype mice. This EPO-GEMM (EPO-based genetically engineered mouse model) platform allows the generation of ten genetically distinct sarcomas on an isogenic background, including the first model of ETV6::NTRK3-driven sarcoma. Comprehensive histological and molecular profiling reveals that this mouse sarcoma cohort recapitulates a spectrum of molecularly diverse sarcomas with gene fusions acting as major determinants of sarcoma biology. Integrative cross-species analyses show faithful recapitulation of human sarcoma subtypes, including expression of relevant immunotherapy targets. Comparison of syngeneic allografting methods enables reliable preservation and scalability of sarcoma-EPO-GEMMs for preclinical treatment trials, such as NTRK inhibitor therapy in an immunocompetent background. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Sarcoma: genetics |2 MeSH |
| 650 | _ | 2 | |a Sarcoma: pathology |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
| 650 | _ | 2 | |a Gene Transfer Techniques |2 MeSH |
| 650 | _ | 2 | |a Electroporation: methods |2 MeSH |
| 650 | _ | 2 | |a Mice, Transgenic |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Mice, Inbred C57BL |2 MeSH |
| 700 | 1 | _ | |a Blösel, Daniel |0 P:(DE-He78)f65c61f32eec3b342ed6eb3a52e976fe |b 1 |u dkfz |
| 700 | 1 | _ | |a Kommoss, Felix Karl-Friedrich |0 P:(DE-He78)0da1ad006d075546f49fd10e062da5d2 |b 2 |
| 700 | 1 | _ | |a Placke, Sara |0 P:(DE-He78)9575bccb859ee2e0db79fec0bf6b5fad |b 3 |u dkfz |
| 700 | 1 | _ | |a Stutheit-Zhao, Eric |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Blume, Christina |0 P:(DE-He78)a4d58b3605bb0818ae8e3092b8c35182 |b 5 |
| 700 | 1 | _ | |a Lupar, Dmitry |0 P:(DE-He78)edc624d702fb751d82cc07962009bcae |b 6 |u dkfz |
| 700 | 1 | _ | |a Schmitt, Lukas |0 P:(DE-He78)5ebf27c73a3f0b66abe1c471997cebb8 |b 7 |
| 700 | 1 | _ | |a Winter, Claudia |0 P:(DE-He78)ad9de99e86896dd6724d014f714587b7 |b 8 |u dkfz |
| 700 | 1 | _ | |a Wagner, Lena |0 P:(DE-He78)dafca537433ee26708b96d89aba38d29 |b 9 |
| 700 | 1 | _ | |a von Eicke, Malte |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Walzer, Hannah |0 P:(DE-He78)ec454fec52583915e0f37bcc23ea1229 |b 11 |u dkfz |
| 700 | 1 | _ | |a Förderer, Julia |0 P:(DE-He78)16a22b660fb9df143d71d8b1697e58f0 |b 12 |u dkfz |
| 700 | 1 | _ | |a Laier, Stephanie |0 P:(DE-He78)e4106a3c510e44f92596378a8af09ba8 |b 13 |u dkfz |
| 700 | 1 | _ | |a Hertwig, Michael |0 P:(DE-He78)d811c22bb53b1f99848cbd50cbb061c3 |b 14 |
| 700 | 1 | _ | |a Peterziel, Heike |0 P:(DE-He78)2727b5cb63b52d0137d4f4e8f110ee7e |b 15 |u dkfz |
| 700 | 1 | _ | |a Oehme, Ina |0 P:(DE-He78)908367a659dea9e28dac34592b3c46e5 |b 16 |u dkfz |
| 700 | 1 | _ | |a Scheuerman, Sophia |0 0000-0003-0487-2773 |b 17 |
| 700 | 1 | _ | |a Seitz, Christian |0 P:(DE-He78)45b51c841f04cc1e504288e68358b4dc |b 18 |u dkfz |
| 700 | 1 | _ | |a Geyer, Florian H |0 P:(DE-He78)824510670ec489266e6e294c4f8b0e6c |b 19 |u dkfz |
| 700 | 1 | _ | |a Cidre-Aranaz, Florencia |0 0000-0002-0246-7179 |b 20 |
| 700 | 1 | _ | |a Grünewald, Thomas |0 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |b 21 |u dkfz |
| 700 | 1 | _ | |a Vokuhl, Christian |b 22 |
| 700 | 1 | _ | |a Chudasama, Priya |0 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |b 23 |u dkfz |
| 700 | 1 | _ | |a Scholl, Claudia |0 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |b 24 |u dkfz |
| 700 | 1 | _ | |a Schmidt, Claudia |0 P:(DE-He78)2a599a43bd0b5910c80edb288d8da3e5 |b 25 |u dkfz |
| 700 | 1 | _ | |a Günther, Patrick |b 26 |
| 700 | 1 | _ | |a Sill, Martin |0 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b |b 27 |u dkfz |
| 700 | 1 | _ | |a Jones, Kevin B |0 0000-0003-1531-2157 |b 28 |
| 700 | 1 | _ | |a Pfister, Stefan |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 29 |u dkfz |
| 700 | 1 | _ | |a Autry, Robert |0 P:(DE-He78)50c2928009c788a6a5f3a0708dfb6df5 |b 30 |u dkfz |
| 700 | 1 | _ | |a Banito, Ana |0 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8 |b 31 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s41467-025-60519-5 |g Vol. 16, no. 1, p. 5283 |0 PERI:(DE-600)2553671-0 |n 1 |p 5283 |t Nature Communications |v 16 |y 2025 |x 2041-1723 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:302111 |p VDB |p OpenAPC |p openCost |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)3c021852cf94cb29825e65baa82ed54b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)f65c61f32eec3b342ed6eb3a52e976fe |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)0da1ad006d075546f49fd10e062da5d2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)9575bccb859ee2e0db79fec0bf6b5fad |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)a4d58b3605bb0818ae8e3092b8c35182 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)edc624d702fb751d82cc07962009bcae |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)5ebf27c73a3f0b66abe1c471997cebb8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)ad9de99e86896dd6724d014f714587b7 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)dafca537433ee26708b96d89aba38d29 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)ec454fec52583915e0f37bcc23ea1229 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)16a22b660fb9df143d71d8b1697e58f0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)e4106a3c510e44f92596378a8af09ba8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)d811c22bb53b1f99848cbd50cbb061c3 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)2727b5cb63b52d0137d4f4e8f110ee7e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)908367a659dea9e28dac34592b3c46e5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 0000-0003-0487-2773 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)45b51c841f04cc1e504288e68358b4dc |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)824510670ec489266e6e294c4f8b0e6c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 0000-0002-0246-7179 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)2a599a43bd0b5910c80edb288d8da3e5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 29 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 30 |6 P:(DE-He78)50c2928009c788a6a5f3a0708dfb6df5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 31 |6 P:(DE-He78)990de6ec6c2f0a40b17ed75162ca19e8 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-01-30T07:48:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-01-30T07:48:07Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2024-01-30T07:48:07Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-01-30T07:48:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-02 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-02 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b NAT COMMUN : 2022 |d 2025-01-02 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2025-01-02 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2025-01-02 |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DOAJ Journal |2 APC |0 PC:(DE-HGF)0003 |
| 920 | 2 | _ | |0 I:(DE-He78)B380-20160331 |k B380 |l NWG Weichteilsarkome |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B380-20160331 |k B380 |l NWG Weichteilsarkome |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)B300-20160331 |k B300 |l KKE Neuropathologie |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)W420-20160331 |k W420 |l Gruppe Müller-Decker |x 4 |
| 920 | 1 | _ | |0 I:(DE-He78)A190-20160331 |k A190 |l A190 Vaskuläre Onkologie und Metastasierung |x 5 |
| 920 | 1 | _ | |0 I:(DE-He78)B310-20160331 |k B310 |l KKE Pädiatrische Onkologie |x 6 |
| 920 | 1 | _ | |0 I:(DE-He78)B410-20160331 |k B410 |l Translationale Pädiatrische Sarkomforschung |x 7 |
| 920 | 1 | _ | |0 I:(DE-He78)B390-20160331 |k B390 |l NWG Präzisions-Sarkomforschung |x 8 |
| 920 | 1 | _ | |0 I:(DE-He78)B290-20160331 |k B290 |l Angewandte Funktionelle Genomik |x 9 |
| 920 | 1 | _ | |0 I:(DE-He78)W210-20160331 |k W210 |l Lichtmikroskopie |x 10 |
| 920 | 0 | _ | |0 I:(DE-He78)B380-20160331 |k B380 |l NWG Weichteilsarkome |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B380-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B300-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W420-20160331 |
| 980 | _ | _ | |a I:(DE-He78)A190-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B310-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B410-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B390-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B290-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W210-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a APC |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|